Xiangxue Pharmaceutical Co.,Ltd.

¥5.08As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300147Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (9.72%)
Div yield —
ROE (386.72%)
Biotechnology
Beta (5Y) 0.67
PE TTM —
TSR TTM (49.85%)
Mkt cap ¥3.359B
ROIC (4.26%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.43
6.99%
9.97%
Hold 4|1|6|7|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.07
0.07
16.07%
17.21%
20.16%
7.07%
Revenue¥M
222.6
227.3
230.9
229.2
10.09%
7.41%
12.12%
6.06%
Peers (US$503.6M)
Cap (US$)
PE
506.5M
66.46x
503.9M
—
Capital
TTM
5Y
10Y
Leveragex
2.604
(0.500)
(0.415)
EBIT/Intx
1.768
0.142
0.158
Own earn%
113.54
(32.52)
(55.24)
Sh yield%
18.80
36.02
35.35
Owners
Insiders/Inst%
11.05
43.48
Short interest%
1.94
SBC / revenue%
4.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
22–29
$1 testx
—
Incr. ROIC%
4